With the manufacturing capacity and access to relevant technology, African countries can reduce their dependency on international manufacturers for vaccines.
One of the consequences of the failure of developing countries like South Africa to authorise self-testing is that it is driving a thriving black market.
A regulatory approach will place an unnecessary burden on bio-innovators. This will discourage local investment for in-house R&D, as well as projects in the public sector.
Masud Ibrahim, AAM University of Skills Training and Entrepreneurial Development and Robert E. Hinson, University of Ghana
The introduction of these technologies in Ghana has created an enabling platform for consumers to use their mobile phones to pay for goods and services
A growing body of research shows that COVID-19 protocols should be extended to areas in which there is a human-animal interface such as zoos, wildlife sanctuaries and game farms.
Dean Faculty of Health Sciences and Professor of Vaccinology at University of the Witwatersrand; and Director of the SAMRC Vaccines and Infectious Diseases Analytics Research Unit, University of the Witwatersrand
Principal Medical Scientist and Head of Laboratory for Antimalarial Resistance Monitoring and Malaria Operational Research, National Institute for Communicable Diseases
Professor and Programme Director, SA MRC Centre for Health Economics and Decision Science - PRICELESS SA (Priority Cost Effective Lessons in Systems Strengthening South Africa), University of the Witwatersrand